2007
DOI: 10.1212/01.wnl.0000267701.58488.69
|View full text |Cite
|
Sign up to set email alerts
|

Clinicopathologic correlation in PGRN mutations

Abstract: PGRN mutations at 17q21 may occur in apparently sporadic frontotemporal lobar dementia with ubiquitinated inclusions cases and in cases presenting with either primary progressive aphasia or the behavioral variant of frontotemporal dementia. Some cases without PGRN mutations also have ubiquitinated neuronal intranuclear inclusions. Clinicopathologic differences are observed among individuals with and without PGRN mutations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
35
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(37 citation statements)
references
References 64 publications
2
35
0
Order By: Relevance
“…More recently, HDDD-2 was associated with ubiquitinpositive, tau-negative pathology due to a PGRN mutation 93 . Two familieswithnaPPA have been described, and this was associated with a PGRN mutation 94,95 . Other reports have described families with naPPA and a behavioral disorder due to a PGRN mutation 96,97 .…”
Section: Genetic Associations Of Nonfluent/agrammatic Primary Progresmentioning
confidence: 99%
“…More recently, HDDD-2 was associated with ubiquitinpositive, tau-negative pathology due to a PGRN mutation 93 . Two familieswithnaPPA have been described, and this was associated with a PGRN mutation 94,95 . Other reports have described families with naPPA and a behavioral disorder due to a PGRN mutation 96,97 .…”
Section: Genetic Associations Of Nonfluent/agrammatic Primary Progresmentioning
confidence: 99%
“…The loss of functional protein is mainly the result of loss of GRN transcript caused by NMD of transcripts containing PTCs (n 5 52) or by nuclear degradation of transcripts retaining the first intron due to splice-site mutations in intron 1 (n 5 2) Le Ber et al, 2007]. PTCs can be the result from nonsense mutations (n 5 12), splice-site mutations (n 5 10), and small insertions/deletions (n 5 30) Baker et al, 2006;Huey et al, 2006;Pickering-Brown et al, 2006Boeve et al, 2006;Masellis et al, 2006;Gass et al, 2006;Benussi et al, 2008;Bronner et al, 2007;Mesulam et al, 2007;Behrens et al, 2007;Leverenz et al, 2007;Bruni et al, 2007;Van Deerlin et al, 2007;Brouwers et al, 2007;Rademakers et al, 2007;Llado et al, 2007;Le Ber et al, 2007;Davion et al, 2007;Kelley et al, in press;Spina et al, 2007a;Mukherjee et al, 2008;Beck et al, 2008;Le Ber et al, 2008]. Second, loss of translation as a result of mutations affecting the Kozak sequence (n 5 4) Baker et al, 2006;Pickering-Brown et al, 2006;Boeve et al, 2006;Gass et al, 2006;Le Ber et al, 2008] and reduction of secreted protein due to missense mutations affecting the signal sequence (n 5 2) [Mukherjee et al, 2006;Gass et al, 2006;Kelley et al, in press;Mukherjee et al, 2008;Le Ber et al, 2008], results in reduced GRN.…”
Section: Grn Mutation Spectrum Null Mutationsmentioning
confidence: 99%
“…However, because of the clinical heterogeneity of GRN mutations, diagnostic screening should also be considered in other neurodegenerative diseases such as clinically diagnosed AD and PD without mutations in other known genes. Even in patients without obvious family history, genetic testing should be considered, since several GRN mutations were found in apparently sporadic patients Le Ber et al, 2007;Davion et al, 2007]. However, the predictive value of genetic testing is not very high because of several difficulties.…”
Section: Diagnostic Relevancementioning
confidence: 99%
“…This concept, defined as molecular nexopathies, hypothesized that GRN mutations cause a specific and preferential involvement of long intrahemispheric tracts between target networks and off-target pathways (i.e., temporoparietal regions). More research is needed to bridge the gap between molecular aspects of FTLD and the neuropathologic alterations driving the clinical and radiologic presentation (39,40). Large international initiatives with multimodal imaging techniques with high-level statistical tools are required to confirm and extend the field of the molecular nexopathies.…”
Section: Discussionmentioning
confidence: 99%